Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2023

17-03-2023 | Streptococci | Invited Commentary

Spontaneous Bacterial Peritonitis: The Bug Matters

Authors: Sunny Sandhu, Binu V. John

Published in: Digestive Diseases and Sciences | Issue 5/2023

Login to get access

Excerpt

Bacterial infections contribute to the morbidity and mortality of patients with cirrhosis, with infection rates up to 34% in hospitalized patients [1]. Spontaneous bacterial peritonitis (SBP) is defined as bacterial infection of the ascitic fluid in the absence of a proven or suspected intra-abdominal source of infection. Despite improvement in treatments, SBP remains associated with a mortality as high as 20%, as well as high recurrence rates after initial infection [2]. Its pathogenesis involves bacterial translocation, likely through specialized epithelial M cells located in the intestinal Peyer’s patches overlying specialized subepithelial mesenteric lymphatic tissue, with bacteria entering the lymphatic circulation and ultimately, the bloodstream in the setting of impaired host defenses and compromised immune function [3]. …
Literature
3.
go back to reference Biggins SW, Angeli P, Garcia-Tsao G et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014–1048. https://doi.org/10.1002/hep.31884.CrossRefPubMed Biggins SW, Angeli P, Garcia-Tsao G et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014–1048. https://​doi.​org/​10.​1002/​hep.​31884.CrossRefPubMed
4.
go back to reference Sajjad M, Khan ZA, Khan MS. Ascitic fluid culture in cirrhotic patients with spontaneous bacterial peritonitis. J Coll Phys. Surg Pak. 2016;26(8):658–661. Sajjad M, Khan ZA, Khan MS. Ascitic fluid culture in cirrhotic patients with spontaneous bacterial peritonitis. J Coll Phys. Surg Pak. 2016;26(8):658–661.
5.
go back to reference Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351–1355.CrossRefPubMed Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351–1355.CrossRefPubMed
7.
go back to reference Fernández J, Prado V, Trebicka J et al. European Foundation for the Study of Chronic Liver Failure (EF-Clif). Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol. 2019;70(3):398–411.CrossRefPubMed Fernández J, Prado V, Trebicka J et al. European Foundation for the Study of Chronic Liver Failure (EF-Clif). Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol. 2019;70(3):398–411.CrossRefPubMed
Metadata
Title
Spontaneous Bacterial Peritonitis: The Bug Matters
Authors
Sunny Sandhu
Binu V. John
Publication date
17-03-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-07865-w

Other articles of this Issue 5/2023

Digestive Diseases and Sciences 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.